Description
A dopamine receptor agonist (Kis = 1,659, 12.2, 12.2, 59.7, and 1,691 nM for dopamine D1-5 receptors, respectively); also binds to 5-HT1A and 5-HT1D (Kis = 12.9 and 10.7 nM, respectively), as well as α1-adrenergic receptors (Kis = 1.12-4.17 nM); restores locomotor activity, without inducing dyskinesia, in a MPTP-induced macaque model of Parkinson’s disease at 5 mg/kg
Formal name: (5α)-2-bromo-12′-hydroxy-2′-(1-methylethyl)-5′-(2-methylpropyl)-errgotaman-3′,6′,18-trione, monomethanesulfonate
Synonyms: CB-154
Molecular weight: 750.7
CAS: 22260-51-1
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Endocrinology & Metabolism|Hormones & Receptors||Research Area|Neuroscience|Neurodegenerative Disorders|Parkinson’s Disease